Diagnostic accuracy of serum Ca 19-9 in predicting malignancy in patients undergoing pancreatic resection.

被引：0
|
作者：
Bekaii-Saab, TS [1 ]
Cowgill, SM [1 ]
Burak, WE [1 ]
Melvin, WS [1 ]
Ellison, EC [1 ]
Muscarella, P [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4210
引用
收藏
页码：365S / 365S
页数：1
相关论文
共 50 条
  • [21] Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder
    Bind, Manoj K.
    Mishra, Ravi R.
    Kumar, Varsha
    Misra, Vatsala
    Singh, Premala A.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (01) : 65 - 68
  • [22] Prognostic value of CA 19-9 serum course in pancreatic cancer
    Safi, F
    Schlosser, W
    Falkenreck, S
    Beger, HG
    HEPATO-GASTROENTEROLOGY, 1998, 45 (19) : 253 - 259
  • [23] Elevated serum CA 19-9 with adnexal mass: is it always an ovarian malignancy?
    Chew, Kah Teik
    Zakaria, Izyan Atiqah
    Abu, Muhammad Azrai
    Ahmad, Mohd Faizal
    Hing, Erica Yee
    Ghani, Nur Azurah Abdul
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2018, 34 (03)
  • [24] Serum determination of CA 19-9 in diagnosing pancreatic cancer: An obituary
    Pezzilli, R.
    Casadei, R.
    Calculli, L.
    Santini, D.
    Morselli-Labate, A. M.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (01) : 73 - 74
  • [25] CA 19-9 AS A PROGNOSTIC INDEX AFTER RESECTION FOR PANCREATIC-CANCER
    SPERTI, C
    PASQUALI, C
    CATALINI, S
    CAPPELLAZZO, F
    BONADIMANI, B
    BEHBOO, R
    PEDRAZZOLI, S
    JOURNAL OF SURGICAL ONCOLOGY, 1993, 52 (03) : 137 - 141
  • [26] Elevated Serum Carcinoembryonic Antigen 19-9 (CA 19-9) Levels Are Highly Specific for Malignancy in Patients Referred for Endoscopic Ultrasound (EUS) With Suspected Pancreatic Cancer but Without a Tissue Diagnosis
    Anderson, Michelle A.
    Sheth, Neil M.
    Scheiman, James
    Plonka, Caitlyn M.
    Zhu, Bin
    Elta, Grace H.
    Kwon, Richard S.
    Piraka, Cyrus R.
    Wamsteker, Erik-Jan
    Elmunzer, B. Joseph
    GASTROENTEROLOGY, 2011, 140 (05) : S714 - S714
  • [27] Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
    Shojiro Hata
    Yoshihiro Sakamoto
    Yusuke Yamamoto
    Satoshi Nara
    Minoru Esaki
    Kazuaki Shimada
    Tomoo Kosuge
    Annals of Surgical Oncology, 2012, 19 : 636 - 641
  • [28] SERUM CA 19-9 IN THE POSTSURGICAL FOLLOW-UP OF PATIENTS WITH PANCREATIC-CANCER
    BERETTA, E
    MALESCI, A
    ZERBI, A
    MARIANI, A
    CARLUCCI, M
    BONATO, C
    FERRARI, AM
    DICARLO, V
    CANCER, 1987, 60 (10) : 2428 - 2431
  • [29] Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
    Kondo, Naru
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Hayashidani, Yasuo
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakashima, Akira
    Sakabe, Ryutaro
    Shigemoto, Norifumi
    Kato, Yasushi
    Ohge, Hiroki
    Sueda, Taijiro
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (09) : 2321 - 2329
  • [30] Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
    Hata, Shojiro
    Sakamoto, Yoshihiro
    Yamamoto, Yusuke
    Nara, Satoshi
    Esaki, Minoru
    Shimada, Kazuaki
    Kosuge, Tomoo
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (02) : 636 - 641
12345